NYSEAMERICAN : YCBD
cbdMD, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 0.3827 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.29M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
cbdMD, Inc. (YCBD) reported revenue of 20.93M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 20.93M | 19.19M | 19.48M | 24.16M | 35.40M | 44.48M |
| Cost of Revenue | 8.86M | 7.22M | 7.49M | 9.18M | 13.07M | 14.50M |
| Gross Profit | 12.07M | 11.97M | 12.00M | 14.98M | 22.34M | 29.99M |
| Selling, General & Admin | 13.52M | 11.99M | 13.27M | 18.93M | 33.29M | 43.37M |
| Research & Development | 22.27K | 33.86K | 39.02K | 173.04K | 633.39K | 1.42M |
| Amortization of Goodwill & Intangibles | 804.03K | 765.08K | 697.51K | 1.40M | 884.38K | |
| Other Operating Expenses | 411.06K | 978.82K | 856.67K | 3.34M | 3.89M | 3.79M |
| Operating Expenses | 14.98M | 14.13M | 15.31M | 24.25M | 39.65M | 49.60M |
| Operating Income | -2.90M | -2.16M | -3.32M | -9.27M | -17.31M | -19.62M |
| Interest Expense | -29.51K | -28.93K | ||||
| Interest & Investment Income | 15.09K | 34.31K | 63.70K | 16.25K | ||
| Other Non Operating Income (Expenses) | 239.25K | 29.48K | ||||
| EBT Excluding Unusual Items | -2.89M | -2.13M | -3.34M | -9.20M | -17.06M | -19.62M |
| Merger & Restructuring Charges | -602.09K | |||||
| Impairment of Goodwill | -56.67M | |||||
| Gain (Loss) on Sale of Investments | -700.00K | -33.35K | 546.88K | |||
| Gain (Loss) on Sale of Assets | 88.77K | |||||
| Asset Writedown | -13.22M | -4.29M | ||||
| Other Unusual Items | 87.38K | -355.21K | 185.64K | 8.47M | -5.22M | |
| Pretax Income | -2.89M | -2.04M | -3.70M | -22.94M | -70.08M | -24.29M |
| Income Tax Expense | -895.00K | |||||
| Earnings From Continuing Operations | -2.89M | -2.04M | -3.70M | -22.94M | -70.08M | -23.39M |
| Net Income | -2.89M | -2.04M | -3.70M | -22.94M | -70.08M | -23.39M |
| Preferred Dividends & Other Adjustments | 191.31K | 2.33M | 4.00M | 4.00M | 4.00M | 2.55M |
| Net Income to Common | -3.08M | -4.38M | -7.70M | -26.94M | -74.09M | -25.95M |
| Shares Outstanding (Basic) | 9.75M | 4.02M | 539.07K | 252.79K | 165.97K | 152.61K |
| Shares Outstanding (Diluted) | 9.75M | 4.02M | 539.07K | 252.79K | 165.97K | 152.61K |
| EPS (Basic) | -0.32 | -1.09 | -14.29 | -106.57 | -446.37 | -170.04 |
| EPS (Diluted) | -0.32 | -1.09 | -14.29 | -106.57 | -446.40 | -170.04 |
| Free Cash Flow | -2.41M | -1.64M | -542.81K | -4.60M | -15.66M | -14.44M |
| Free Cash Flow Per Share | -0.25 | -0.41 | -1.01 | -18.20 | -94.33 | -94.59 |
| Gross Margin | 57.68% | 62.37% | 61.57% | 62.01% | 63.09% | 67.41% |
| Operating Margin | -13.87% | -11.27% | -17.02% | -38.37% | -48.89% | -44.10% |
| Profit Margin | -14.71% | -22.80% | -39.55% | -111.53% | -209.26% | -58.34% |
| Free Cash Flow Margin | -11.51% | -8.53% | -2.79% | -19.04% | -44.22% | -32.45% |
| EBITDA | -1.89M | -1.04M | -2.17M | -7.47M | -15.48M | -18.60M |
| EBITDA Margin | -9.01% | -5.40% | -11.12% | -30.92% | -43.72% | -41.81% |
| D&A For EBITDA | 1.02M | 1.13M | 1.15M | 1.80M | 1.83M | 1.02M |
| EBIT | -2.90M | -2.16M | -3.32M | -9.27M | -17.31M | -19.62M |
| EBIT Margin | -13.87% | -11.27% | -17.02% | -38.37% | -48.89% | -44.10% |
| Revenue as Reported | 20.93M | 19.19M | 19.48M | 24.16M | 35.40M | 44.48M |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.12M | 2.26M | 2.45M | 1.80M | 6.72M | 26.41M |
| Short-Term Investments | 1.00M | 1.03M | ||||
| Cash & Short-Term Investments | 2.12M | 2.26M | 2.45M | 1.80M | 7.72M | 27.44M |
| Accounts Receivable | 1.75M | 1.04M | 983.91K | 1.22M | 1.45M | 1.11M |
| Receivables | 1.75M | 1.04M | 983.91K | 1.22M | 1.45M | 1.11M |
| Inventory | 3.47M | 2.95M | 2.52M | 4.24M | 4.77M | 5.57M |
| Prepaid Expenses | 339.16K | 277.15K | 406.67K | 750.38K | 701.95K | 1.15M |
| Other Current Assets | 21.16K | 25.23K | 21.75K | 70.06K | 1.37M | 1.22M |
| Total Current Assets | 7.70M | 6.55M | 6.39M | 8.07M | 16.01M | 36.50M |
| Property, Plant & Equipment | 2.52M | 981.31K | 540.09K | 4.07M | 5.30M | 8.18M |
| Long-Term Investments | 700.00K | 700.00K | 700.00K | 700.00K | 1.40M | |
| Goodwill | 190.00K | 56.67M | ||||
| Other Intangible Assets | 1.98M | 2.12M | 2.89M | 3.22M | 17.83M | 23.00M |
| Other Long-Term Assets | 62.71K | 62.71K | 62.71K | 138.71K | 244.61K | 529.58K |
| Total Assets | 13.15M | 10.42M | 10.58M | 16.20M | 40.79M | 124.88M |
| Accounts Payable | 1.49M | 1.17M | 1.54M | 1.91M | 2.04M | 2.98M |
| Accrued Expenses | 587.77K | 735.67K | 632.67K | 632.20K | 2.06M | 2.73M |
| Short-Term Debt | 7.32K | 1.17M | 2.49K | 9.61K | 59.47K | |
| Current Portion of Leases | 350.95K | 778.24K | 98.70K | 1.28M | 1.18M | 1.15M |
| Current Unearned Revenue | 570.25K | 506.29K | 503.25K | 185.25K | ||
| Other Current Liabilities | 71.03K | 4.67M | 667.00K | |||
| Total Current Liabilities | 3.08M | 3.19M | 8.62M | 4.67M | 5.29M | 6.92M |
| Long-Term Leases | 1.85M | 2.40M | 3.68M | 4.86M | ||
| Other Long-Term Liabilities | 90.37K | 401.49K | 9.96M | |||
| Total Liabilities | 4.93M | 3.19M | 8.62M | 7.16M | 9.37M | 21.74M |
| Common Stock | 11.12K | 8.92K | 492.00 | 2.96K | 1.35K | 57.78K |
| Additional Paid-In Capital | 190.03M | 186.65M | 184.03M | 183.39M | 178.84M | 176.42M |
| Retained Earnings | -181.83M | -179.44M | -182.07M | -174.36M | -147.42M | -73.34M |
| Comprehensive Income & Other | -7.19K | |||||
| Total Common Equity | 8.21M | 7.22M | 1.96M | 9.03M | 31.42M | 103.14M |
| Shareholders' Equity | 8.21M | 7.23M | 1.96M | 9.03M | 31.42M | 103.14M |
| Total Liabilities & Equity | 13.15M | 10.42M | 10.58M | 16.20M | 40.79M | 124.88M |
| Total Debt | 2.21M | 778.24K | 1.27M | 3.68M | 4.87M | 6.07M |
| Net Cash (Debt) | -93.92K | 1.48M | 1.18M | -1.89M | 2.85M | 21.38M |
| Net Cash Per Share | -0.01 | 0.37 | 2.19 | -7.46 | 17.18 | 140.07 |
| Filing Date Shares Outstanding | 11.21M | 9.42M | 692.39K | 370.12K | 168.56K | 160.57K |
| Total Common Shares Outstanding | 11.12M | 8.92M | 492.38K | 370.07K | 168.52K | 160.51K |
| Working Capital | 4.62M | 3.36M | -2.23M | 3.40M | 10.73M | 29.59M |
| Book Value Per Share | 0.74 | 0.81 | 3.98 | 24.39 | 186.45 | 642.56 |
| Tangible Book Value | 6.04M | 5.10M | -931.16K | 5.81M | 13.58M | 23.46M |
| Tangible Book Value Per Share | 0.54 | 0.57 | -1.89 | 15.69 | 80.61 | 146.17 |
| Machinery | 2.24M | 2.05M | 1.87M | 1.69M | 1.39M | 3.55M |
| Leasehold Improvements | 499.82K | 495.58K | 487.08K | 487.08K | 487.08K | 870.62K |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -2.89M | -2.04M | -3.70M | -22.94M | -70.08M | -23.39M |
| Depreciation & Amortization | 1.71M | 1.80M | 1.82M | 2.93M | 2.97M | 2.25M |
| Loss (Gain) From Sale of Assets | -322.02K | |||||
| Asset Writedown & Restructuring Costs | 13.22M | 60.96M | ||||
| Loss (Gain) From Sale of Investments | 700.00K | 941.12K | 324.51K | |||
| Stock-Based Compensation | 376.94K | 100.78K | 16.90K | 342.87K | 928.83K | 3.02M |
| Provision & Write-off of Bad Debts | 382.59K | 382.59K | 54.32K | |||
| Other Operating Activities | 365.98K | 278.60K | 1.97M | 874.75K | -7.60M | 6.09M |
| Change in Accounts Receivable | -1.15M | -439.56K | 177.86K | 278.48K | 65.54K | -183.74K |
| Change in Inventory | -389.26K | -788.71K | 790.14K | 356.23K | -72.13K | -1.27M |
| Change in Accounts Payable | 10.51K | -261.88K | -1.12M | -1.29M | -1.81M | -104.42K |
| Change in Unearned Revenue | -18.29K | 3.10K | 318.01K | 203.34K | 203.34K | 3.72K |
| Change in Other Net Operating Assets | -623.45K | -482.30K | -679.01K | 1.02M | -1.16M | -372.30K |
| Operating Cash Flow | -2.22M | -1.45M | -352.79K | -4.30M | -14.97M | -14.09M |
| Capital Expenditures | -191.42K | -184.17K | -190.01K | -297.55K | -688.68K | -342.01K |
| Cash Acquisitions | 56.43K | -2.00M | ||||
| Sale (Purchase) of Intangibles | -100.00K | |||||
| Investment in Securities | 1.00M | -210.00K | ||||
| Investing Cash Flow | -134.99K | -184.17K | -290.01K | 702.45K | -688.68K | -2.55M |
| Short-Term Debt Issued | 1.25M | |||||
| Total Debt Issued | 61.99K | 1.25M | ||||
| Short-Term Debt Repaid | -132.60K | -33.35K | -151.55K | |||
| Total Debt Repaid | -132.60K | -33.35K | -151.55K | |||
| Net Debt Issued (Repaid) | 61.99K | 1.25M | -132.60K | -33.35K | -151.55K | |
| Issuance of Common Stock | 50.00K | 2.48M | ||||
| Preferred Dividends Paid | -3.67M | -4.00M | -2.55M | |||
| Dividends Paid | -120.28K | -3.67M | -4.00M | -2.55M | ||
| Financing Cash Flow | 3.41M | 1.45M | 1.30M | -1.32M | -4.04M | 28.23M |
| Net Cash Flow | 1.06M | -191.31K | 654.69K | -4.92M | -19.69M | 11.59M |
| Free Cash Flow | -2.41M | -1.64M | -542.81K | -4.60M | -15.66M | -14.44M |
| Free Cash Flow Margin | -11.51% | -8.53% | -2.79% | -19.04% | -44.22% | -32.45% |
| Free Cash Flow Per Share | -0.25 | -0.41 | -1.01 | -18.20 | -94.33 | -94.59 |
| Levered Free Cash Flow | -1.05M | -4.93M | 5.78M | -1.50M | -8.26M | -7.48M |
| Unlevered Free Cash Flow | -1.05M | -4.93M | 5.79M | -1.50M | -8.26M | -7.46M |
| Cash Interest Paid | 74.64K | 6.40K | 2.36K | 33.69K | ||
| Change in Working Capital | -2.17M | -1.97M | -517.15K | 570.45K | -2.77M | -2.82M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.29M | 10.78M | 1.80M | 2.96M | 13.63M | 120.17M |
| Enterprise Value | 4.38M | 10.69M | 3.52M | 4.10M | 8.23M | 106.56M |
| Last Close Price | 0.38 | 1.21 | 3.76 | 8.28 | 81.04 | 748.80 |
| PS Ratio | 0.20 | 0.56 | 0.09 | 0.12 | 0.39 | 2.70 |
| PB Ratio | 0.52 | 1.49 | 0.92 | 0.33 | 0.43 | 1.17 |
| P/TBV Ratio | 0.71 | 2.12 | 0.51 | 1.00 | 5.12 | |
| EV/Sales Ratio | 0.21 | 0.56 | 0.18 | 0.17 | 0.23 | 2.40 |
| Debt / Equity Ratio | 0.27 | 0.11 | 0.65 | 0.41 | 0.15 | 0.06 |
| Debt / EBITDA Ratio | 28.33 | 2.21 | 2.48 | |||
| Net Debt / Equity Ratio | 0.01 | -0.20 | -0.60 | 0.21 | -0.09 | -0.21 |
| Net Debt / EBITDA Ratio | -0.05 | 1.43 | 0.55 | -0.25 | 0.18 | 1.15 |
| Net Debt / FCF Ratio | -0.04 | 0.91 | 2.18 | -0.41 | 0.18 | 1.48 |
| Asset Turnover | 1.82 | 1.83 | 1.46 | 0.85 | 0.43 | 0.38 |
| Inventory Turnover | 2.67 | 2.64 | 2.21 | 2.04 | 2.53 | 2.77 |
| Quick Ratio | 1.26 | 1.03 | 0.40 | 0.65 | 1.74 | 4.13 |
| Current Ratio | 2.50 | 2.05 | 0.74 | 1.73 | 3.03 | 5.28 |
| Return on Equity (ROE) | -40.33% | -44.42% | -67.31% | -113.40% | -104.16% | -25.66% |
| Return on Assets (ROA) | -15.75% | -12.87% | -15.48% | -20.33% | -13.06% | -10.40% |
| Return on Capital Employed (ROCE) | -28.80% | -29.90% | -168.90% | -80.40% | -48.80% | -16.60% |
| Earnings Yield | -82.51% | -18.92% | -205.10% | -775.50% | -514.15% | -19.47% |
| FCF Yield | -56.18% | -15.17% | -30.09% | -155.50% | -114.85% | -12.01% |
| Buyback Yield / Dilution | -382.43% | -646.22% | -113.25% | -52.31% | -8.76% | -21.62% |